Atlas FDA

DETOUR System

FDA premarket approval P220021/S004 · decided 2025-03-03

Approval details

PMA number
P220021
Supplement
S004
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
DETOUR System
Generic name
Stent graft, bypass, superficial femoral artery
Applicant
Endologix, LLC
Date received
2025-02-07
Decision date
2025-03-03
Days to decision
24 days
Decision code
OK30
Product code
QWM
Advisory committee
Cardiovascular
Expedited review
No
Location
Santa Rosa, CA
Statement
approval for processing changes to the outer shaft of the stent graft delivery system

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.